ConditionLiver Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital of Patras
About this trial
Subjects with large inoperable liver tumors defined as at least 1 lesion larger than 5cm in maximum diameter. For the purposes of the present study, we define the AMARA principle in intensified regional TARE as a planned irradiated tumor dose \>200Gy by the partition model. The purpose of the study is to evaluate the safety and efficacy of Y90 high dose radioembolization for the management of large inoperable liver tumors. In addition, to correlate the safety and efficacy with the post-treatment dosimetry analysis (by MIM Software Inc) based on 90Y-PET/CT imaging.
Eligibility criteria
Qualifiers
Age >18 yr
Both sexes eligible for study
Patients with primary or secondary liver tumors
Liver dominant disease
Disqualifiers
Child Pugh > B
Bilirubin >2 mg/dl
Albumin<3.0
Central portal invasion
Trial design
Treatments tested in this trial
- Transarterial Radioembolization
Treatment groups
100 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov